Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-13 | Jeffrey A. Bailey: Mr. Bailey is a seasoned operational healthcare executive with over 30 years of leadership experience within the healthcare industry... He serves on the Governance and Nominating Committee of each Fund. The members of each Fund's Valuation Committee are Mr. Bailey, Mr. Kent, Dr. Omstead, Mr. Pohotsky and Mr. Reardon. Mr. Pohotsky is the Chairman of each Fund's Valuation Committee. The members of each Fund's Governance and Nominating Committee are Mr. Bailey, Dr. Jain, Mr. Pohotsky and Ms. Stebbins. Ms. Stebbins is the Chairman of the Committee. Compensation Table shows Jeffrey A. Bailey total compensation from all funds as $9,708. |
| 2022-04-12 | Jeffrey A. Bailey: Mr. Bailey is a seasoned operational healthcare executive with over 30 years of leadership experience within the healthcare industry. Mr. Bailey serves as Vice Chairman, on the Valuation Committee and on the Governance and Nominating Committee of each Fund. The members of each Fund's Audit Committee are Mr. Kent, Mr. Reardon and Ms. Goetz. Mr. Kent is the Chairman of each Fund's Audit Committee. The members of each Fund's Valuation Committee are Mr. Bailey, Ms. Goetz, Dr. Omstead and Mr. Reardon. The Valuation Committee of each Fund held four meetings during the fiscal year ended September 30, 2021. For the fiscal year ended September 30, 2021, the Independent Trustees as a group received $104,250. Jeffrey A. Bailey's total compensation was $104,250. |
| 2023-04-11 | Mr. Bailey is a seasoned operational healthcare executive with over 30 years of leadership experience within the healthcare industry. He serves as Chairman of the Board of Trustees and also on the Valuation Committee and on the Governance and Nominating Committee of each Fund. For the fiscal year ended September 30, 2022, the Independent Trustees as a group received $2,098 from HQH, $2,037 from THQ and $1,140 from THW for reimbursed expenses. The following table sets forth information regarding compensation of the Trustees and Executive Officer by each Fund for the fiscal year ended September 30, 2022... Jeffrey A. Bailey $120,083 total compensation. |
| 2023-07-10 | Jeffrey A. Bailey serves as Chairman of the Board of Trustees and also on the Valuation Committee and on the Governance and Nominating Committee of the Fund. For the fiscal year ended September 30, 2022, he received $30,021 from each Fund, totaling $120,083. |
| 2024-04-22 | Mr. Bailey is a seasoned operational healthcare executive with over 30 years of leadership experience within the healthcare industry. He serves as Chairman of the Board of Trustees and also on the Valuation Committee and on the Governance and Nominating Committee of each Fund. The members of each Fund's Audit Committee are Mr. Bailey, Ms. DiMartino, Ms. Goetz, Mr. Maher and Mr. Reit. Mr. Maher is the Chair of each Fund's Audit Committee and is the Audit Committee Financial Expert. The members of each Fund's PV Valuation Committee are Mr. Bailey, Ms. Goetz and Mr. Maher. Mr. Bailey is the Chair of the Fund's PV Valuation Committee. The following table sets forth information regarding compensation: Jeffrey Bailey total $146,000. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-13 | Jeffrey A. Bailey: Mr. Bailey is a seasoned operational healthcare executive with over 30 years of leadership experience within the healthcare industry... He serves on the Governance and Nominating Committee of each Fund. The members of each Fund's Valuation Committee are Mr. Bailey... For the fiscal year ended September 30, 2020, the Independent Trustees as a group received $9,708 for Mr. Bailey. |
| 2022-04-12 | Mr. Bailey serves as Vice Chairman, on the Valuation Committee and on the Governance and Nominating Committee of the Fund. Compensation Table shows total compensation of $104,250. |
| 2023-04-11 | Mr. Bailey is a seasoned operational healthcare executive with over 30 years of leadership experience within the healthcare industry. Mr. Bailey serves as Chairman of the Board of Trustees and also on the Valuation Committee and on the Governance and Nominating Committee of the Fund. Compensation Table shows total compensation from all funds in fund complex paid to Mr. Bailey is $120,083. |
| 2023-07-10 | Jeffrey A. Bailey Year of Birth: 1962 Trustee CEO, IlluminOss Inc. (2018-2020); Board Chairman, Aileron Therapeutics Inc. (since 2017); Director, Madison Vaccines, Inc. (since 2018); Director and CEO, BioDelivery Systems, Inc. (2020-2022). ... He serves as Chairman of the Board of Trustees and also on the Valuation Committee and on the Governance and Nominating Committee of the Fund. ... For the fiscal year ended September 30, 2022, the Independent Trustees as a group received $2,098 from HQH, $898 from HQL, $2,037 from THQ and $1,140 from THW for reimbursed expenses. ... The following table sets forth information regarding compensation of the Trustees and Executive Officer by each Fund for the fiscal year ended September 30, 2022, but does not include reimbursed expenses as described above. ... Jeffrey A. Bailey $30,021 $30,021 $30,021 $30,021 N/A N/A $120,083 |
| 2024-04-22 | Mr. Bailey is a seasoned operational healthcare executive with over 30 years of leadership experience within the healthcare industry. Mr. Bailey has extensive business development and transactional expertise, with diverse leadership experiences in commercial and supply chain management, finance, business development and product development for various pharmaceutical medical device companies. He serves as Chairman of the Board of Trustees and also on the Valuation Committee and on the Governance and Nominating Committee of the Fund. |
Data sourced from SEC filings. Last updated: 2026-02-03